AI Article Synopsis
- After a bone fracture, the body loses more calcium and phosphorus than it takes in, possibly due to stress and certain hormones.
- A study on rats explored whether a substance called hydrogen sulfide (HS) could help prevent this loss by affecting those hormones.
- The results showed that HS reduced hormone levels and helped the kidney keep more calcium and phosphorus, suggesting it might protect bones after fractures.
Article Abstract
Aims: Post-fracture calcium and phosphorus excretion is greater than influx, which might be caused by stress. Glucocorticoid is known to enhance calcium and phosphorous excretion, and hydrogen sulfide (HS) has been shown to exert inhibitory effects on glucocorticoid. Therefore, this study explored whether HS could inhibit calcium and phosphorus loss after fracture by regulating glucocorticoid and/or its receptor.
Main Methods: The following properties were analyzed in rats with femur fractures: serum and urinary calcium and phosphorus (by colorimetry); bone turnover markers alkaline phosphatase, serum type 1 collagen amino terminal peptide, type 1 procollagen carboxy terminal peptide, and anti-tartaric acid phosphatase (by ELISA); factors related to calcium-phosphorus metabolism including glucocorticoid, parathyroid hormone, calcitonin, fibroblast growth factor 23, and 1,25(OH)D (by ELISA); and sulfhydration of glucocorticoid receptor α in the kidney (by immunoprecipitation linked biotin-switch assay), after supplementing with mifepristone, the HS donor GYY4137 or HS generating enzyme inhibitors aminooxyacetic acid and propargylglycine.
Key Findings: Serum HS decreased and glucocorticoid secretion increased in rats post-fracture. The glucocorticoid receptor inhibitor mifepristone partly blunted calcium and phosphorus loss. Furthermore, supplementation with GYY4137 reduced glucocorticoid secretion; inhibited glucocorticoid receptor α activity by sulfhydration; downregulated vitamin D 1α-hydroxylase expression; and upregulated 24-hydroxylase, calbindin-D28k, and sodium phosphate cotransporter 2a expression in the kidney; thereby inhibiting calcium and phosphorus loss induced by fracture. Moreover, inhibiting endogenous HS generation showed opposite effects.
Significance: Our findings suggest that HS antagonized calcium and phosphorus loss after fracture by reducing glucocorticoid secretion and inhibiting glucocorticoid receptor α activity by sulfhydration.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.lfs.2021.119363 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
An Overview on Bioactive Glasses for Bone Regeneration and Repair: Preparation, Reinforcement, and Applications.
Tissue Eng Part B Rev
January 2025
Materials Science and Engineering, School of Materials and Chemistry, University of Shanghai for Science & Technology, Shanghai, China.
Synthetic bone transplantation has emerged in recent years as a highly promising strategy to address the major clinical challenge of bone tissue defects. In this field, bioactive glasses (BGs) have been widely recognized as a viable alternative to traditional bone substitutes due to their unique advantages, including favorable biocompatibility, pronounced bioactivity, excellent biodegradability, and superior osseointegration properties. This article begins with a comprehensive overview of the development and success of BGs in bone tissue engineering, and then focuses on their composite reinforcement systems with biodegradable metals, calcium-phosphorus (Ca-P)-based bioceramics, and biodegradable medical polymers, respectively.
View Article and Find Full Text PDFPreparation of a lanthanum-modified flocculant and its removal performance towards phosphorus and fluoride in yellow phosphorus wastewater.
RSC Adv
January 2025
Faculty of Chemical Engineering, Kunming University of Science and Technology Kunming 650500 P. R. China
Polysilicate-ferric-calcium-lanthanum (PSFCL) was synthesized through a co-polymerization method in order to treat the yellow phosphorus wastewater. Its morphology, composition and functional group were analyzed by X-ray Diffraction (XRD), Fourier Transform-Infrared Spectroscopy (FTIR), Scanning Electron Microscopic (SEM) and X-ray Photoelectron Spectroscopy (XPS), respectively. The optimization of the flocculant was also investigated, including La/Si molar ratio, pH, agitation time, dosage and sedimentation time.
View Article and Find Full Text PDFMagnesium intake and serum magnesium concentration in children with type 1 diabetes mellitus: association with glycemic control and clinical symptoms.
Front Nutr
December 2024
Department of Children's Diseases and Pediatric Surgery, I. Horbachevsky Ternopil National Medical University, Ternopil, Ukraine.
Introduction: Magnesium is involved in numerous reactions that regulate the functioning of different organs and systems. Hypomagnesemia impacts on the development of various metabolic disorders, including insulin resistance and diabetes mellitus (DM). Studying magnesium levels in children with type 1 DM is crucial, as deficiencies are linked to many diabetes complications.
View Article and Find Full Text PDF[Certain key questions in the diagnosis and treatment of primary osteoporosis and other disorders related to abnormal calcium and phosphorus metabolism].
Zhonghua Yi Xue Za Zhi
January 2025
Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai200025, China.
When diagnosing and treating primary osteoporosis and various calcium-phosphorus metabolism disorders, we must pay attention to some key points: diagnosing primary osteoporosis only after excluding secondary factors; understanding the features of various calcium supplements and anti-osteoporosis drugs; and selecting appropriate medications; foreseeing the changes in calcium-phosphorus metabolism after using anti-osteoporosis drugs. This article delves into the aforementioned key issues in the diagnosis and treatment of primary osteoporosis and various disorders of calcium and phosphorus metabolism. It emphasizes the pathophysiological mechanisms, diagnostic criteria, rational drug use, and precautions for primary osteoporosis and various disorders of calcium and phosphorus metabolism, aiming to enhance the level of disease diagnosis and treatment through a holistic thinking.
View Article and Find Full Text PDFAuthor Correction: TNF inhibitors target a mevalonate metabolite/TRPM2/calcium signaling axis in neutrophils to dampen vasculitis in Behçet's disease.
Nat Commun
January 2025
Department of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases, The Ministry of Education Key Laboratory, Beijing, China.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!